TABLE 1.
Escherichia coli and Salmonella strains with associated plasmids
| Bacterial strain | Species | Role | Plasmid | Plasmid size (kb) | Antibiotic resistance | Reference or source |
|---|---|---|---|---|---|---|
| CVM29188 | S. enterica serovar Kentucky | Donor | pCVM29188_146 | 146 | Aminoglycosides, tetracyclines | 30 |
| pCVM29188_101 | 101 | Cephalosporins, quaternary ammonium compounds | ||||
| pCVM29188_46 | 46 | —a | ||||
| DH5α:ASF16S | E. coli | 16S rRNA vector | pCR2.1 | 3.9 | Ampicillin | 26 |
| HS-4 | E. coli (human gut commensal) | Recipient | None | — | — | 50 |
| HS-4 Nalr | E. coli | Recipient | None | — | Spontaneous nalidixic acid-resistant mutant | This study |
| MGN026 | E. coli (DH5α derivative) | Recipient | None | — | — | 51 |
| MGN026 Nalr | E. coli | Recipient | None | — | Spontaneous nalidixic acid-resistant mutant | This study |
a
—, not applicable.